Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
17 Cards in this Set
- Front
- Back
Pharmacodynamics |
Affect of the drug on the body |
|
Pharmacokinetics |
Affect of the body on the drug |
|
Indication/Contra-indication |
Indication = condition where drug is helpful Contraindication = condition in which drug not safe |
|
Antagonist, Agonist |
Agonist - stimulates recepttor action Antagonist - blocks receptor action |
|
Reversible vs Irreversible drugs |
Reversible - dissociates from receptor leaving receptor still functional Irreversible - drug does not dissociate, bound drug and receptor internalized and broken down, not able to be used again until new drug synthesized |
|
Use dependant drugs |
Only exert effects on activated receptors. |
|
Drug half life |
time taken for a 50% decrease in the drug concentration of the plasma. determined by Vd and clearance |
|
Explain solubility of ionised vs unionised drugs Explain effects of pH on acidic/basic drugs |
Ionized - water soluble Unionized - lipid soluble Acidic - ionized in basic enviro/unionized in acidic Basic - ionized in acidic enviro/unionized in basic So you want a basic drug in a basic enviro/acidic drug in acidic enviro for movement across membranes |
|
Ligand-gated ion channels |
Time – milliseconds Ligand (drug) binds to ion channel -> conformational change in structure -> opens channel -> ions pass through channel tointerior/exterior of cell -> hyperpolarization/depolarization |
|
G protein coupled receptors |
Time – seconds. V. common. Ligand binds tomembrane bound receptor. Part of receptor inside cell bound to G protein (αβγ)with GDP attached to α subunit. Ligand binds receptor site -> G protein changesconfirmation, GTP replaces GDP on α subunit. activated α subunit seperates fromβγ subunits -> α subunitactivates target. If 2 targets – βγ subunits activate other target. cAMP may act as secondary messenger to signal furtherintracellular events. |
|
Kinase-linked receptors |
Time – hours. Membrane receptors respond mainly to protein mediators eg. Cytokines Ligand binds receptor -> receptors undergo dimerization (2 receptorscome together – coupling). -> Phosphorylation inside cell – addition of phosphategroups to end of receptors inside cell -> intracellular effects due tophosphorylation. |
|
Intracellular/Nuclear Receptors |
Time – hours (involves protein synthesis). Receptors that regulate gene transmission -> up/down regulation of protein synthesis Ligand diffuses through membrane à cytoplasm. Ligand binds -> inactivated receptor (eg. Transcriptonfactor). Ligand + receptor migrate -> nucleus and are ACTIVATED. Complex ->transcription of DNA à protein synthesis |
|
Volume of distribution |
Volume ofdistribution: volume of fluid required to contain the total amount of drug inthe body at the same concentration as is present in the plasma. Drugs with Vdsimilar to plasma conc – most of drug remains in plasma. High Vd = low plasmaconc. -> slower elimination. Vd = dose/plasmaconcentration. Half life directlyproportional to Vd – Vd determines elimination rate, which determines halflife. |
|
2 phases of metabolism |
1. Oxidation, reduction, hydrolysis or hydration by enzyme eg. cytochrome p450 2. Conjugation– synthesis of bond between drug and metabolite (exogenous substrate) -> polar molecule that can move through waterto be excreted, and is less biologically active. |
|
Loading dose |
High initial dose that gets plasma concentrationto therapeutic range. Dose then tapered in order to maintain plasmaconcentration in therapeutic range. |
|
Steady State |
level we aim to keep plasma conc. at for greatertherapeutic effects, but decreased side effects. generally takes 4-5 half lives. Drugs with high half life may require loading dose. |
|
Clearance |
sum of metabolism andelimination. Relates plasma conc. of drug to eliminationrate – efficiency of drug elimination from body. High clearance -> low half life. High plasma conc -> fast elimination rate. |